Shahram Salek-Ardakani

Insider Reports History

Entity
Individual
Location
C/O Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla, CA
Signature
/s/ Maria Dobek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shahram Salek-Ardakani:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 114K Jan 3, 2022 Direct

Insider Reports Filed by Shahram Salek-Ardakani

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Scientific Officer
JANX Janux Therapeutics, Inc. Jul 12, 2021 0 $0 3 Jul 20, 2021 Chief Scientific Officer